Correlation Between Adamis Pharma and Sunshine Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adamis Pharma and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adamis Pharma and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adamis Pharma and Sunshine Biopharma, you can compare the effects of market volatilities on Adamis Pharma and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adamis Pharma with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adamis Pharma and Sunshine Biopharma.

Diversification Opportunities for Adamis Pharma and Sunshine Biopharma

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Adamis and Sunshine is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Adamis Pharma and Sunshine Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Adamis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adamis Pharma are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Adamis Pharma i.e., Adamis Pharma and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Adamis Pharma and Sunshine Biopharma

If you would invest  282.00  in Sunshine Biopharma on September 1, 2024 and sell it today you would earn a total of  4.00  from holding Sunshine Biopharma or generate 1.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy4.76%
ValuesDaily Returns

Adamis Pharma  vs.  Sunshine Biopharma

 Performance 
       Timeline  
Adamis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adamis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Adamis Pharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Sunshine Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Sunshine Biopharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Adamis Pharma and Sunshine Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adamis Pharma and Sunshine Biopharma

The main advantage of trading using opposite Adamis Pharma and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adamis Pharma position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.
The idea behind Adamis Pharma and Sunshine Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency